Anti-Oxidative, Anti-Apoptotic, and M2 Polarized DSPC Liposome Nanoparticles for Selective Treatment of Atherosclerosis
International Journal of Nanomedicine · 2023
DOI: 10.2147/ijn.s384675 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2023. Verfasst von Jun Wan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Atherosclerosis, Plaque, Atherosclerotic, Nanoparticles. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Zitieren
APA
Wan, J., Yang, J., Lei, W., Xiao, Z., Zhou, P., Zheng, S., & Zhu, P. (2023). Anti-Oxidative, Anti-Apoptotic, and M2 Polarized DSPC Liposome Nanoparticles for Selective Treatment of Atherosclerosis. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s384675
Vancouver
Wan J, Yang J, Lei W, Xiao Z, Zhou P, Zheng S, et al. Anti-Oxidative, Anti-Apoptotic, and M2 Polarized DSPC Liposome Nanoparticles for Selective Treatment of Atherosclerosis. International Journal of Nanomedicine. 2023. doi:10.2147/ijn.s384675
BibTeX
@article{Wan2023,
author = {Wan, Jun and Yang, Jie and Lei, Wenrui and Xiao, Zezhou and Zhou, Pengyu and Zheng, Shaoyi and Zhu, Peng},
title = {Anti-Oxidative, Anti-Apoptotic, and M2 Polarized DSPC Liposome Nanoparticles for Selective Treatment of Atherosclerosis},
journal = {International Journal of Nanomedicine},
year = {2023},
doi = {10.2147/ijn.s384675}
}
EUVIMED